Dr. Patricia Londoño-Hayes Senior Director and Head of Research & Development Initiatives in Europe for Sanofi Pasteur. Patricia Londoño-Hayes, has 18 years of experience in the Discovery, Research and Development of vaccines and monoclonal antibodies. Her track record includes leading both programmes and teams at the scientific, operational and strategic level, in the biotechnology and pharmaceutical sectors. As head of Preclinical Research & Development at Sanofi Pasteur, Patricia directed the preclinical pharmacology evaluation and translational research activities in support of the global portfolio of vaccine candidates at all stages of development, including those for Influenza, C. difficile, HSV, Pertussis and Dengue. In her current alliance management role, Patricia is responsible for accessing and connecting with innovators in the European ecosystem on behalf of Sanofi Pasteur.
Dr. Catherine Caillet is Head of the immuno-microbiology platform in the Preclinical and Translational Research department of Sanofi Pasteur. She has extensive expertise in vaccine immunology, including development of immune-monitoring methods, and immunological characterisation of cellular and humoral immune responses for numerous vaccine candidates in various animal models and in humans. Catherine is co-leader of WP1 (Standardisation of HAI and VN assays).